Current Pharmaceutical Biotechnology

Papers
(The H4-Index of Current Pharmaceutical Biotechnology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Acknowledgement to Reviewers74
Strategy of Virtual Screening based Discovery of HSP90 C-terminal Inhibitors and Network Pharmacological Analysis46
A Review on Edible Vaccines and Biopharmaceutical Products from Plants45
Polygonati Rhizoma Alleviates Vascular Dementia through Regulating Microglial Polarization Transitions Mediated by NF-κB/NLRP3 Pathway43
Spray Drying: A Promising Technique for Inhalable Vaccine Development41
An Exploration of Organoid Technology: Present Advancements, Applications, and Obstacles40
Systematic Review on Herbal Preparations for Controlling Visceral Hypersensitivity in Functional Gastrointestinal Disorders38
Hydrogel Breakthroughs in Biomedicine: Recent Advances and Implications35
Potential Pathogens Associated with Colorectal Cancer34
Xiaoyao Pill Improves the Affective Dysregulation of Sleep-deprived Female Mice by Inhibiting Brain Injury and Regulating the Content of Monoamine Neurotransmitter31
Exploring Therapeutic Frontiers: Unveiling the Potential of Natural Diterpenoid Derivatives in Addressing Neurological Disorders31
Astaxanthin Attenuates Adiponectin, Calprotectin, miRNA222 and miRNA378 in Obesity induced by High-Fat Diet in Rats30
Tryptophan Stability and Palatability in the Food Formulation: A Review30
Genotoxic Impurities in Critical Analysis of Product Development: Recent Advancements, Patents, and Current Challenges30
Diagnostic Accuracy and Validity of Serological and Molecular Tests for Hepatitis B and C29
Bacteriophages: from Isolation to Application29
Role of Medicinal Plants against Neurodegenerative Diseases28
Nerolidol-potential Therapeutic Agent for Various Neurological Disorders via its Antioxidative Property27
The Rhodamine B-encrypted Vipericidin Peptide, RhoB-Ctn[1-9], Displays In vitro Antimicrobial Activity Against Opportunistic Bacteria and Yeasts27
Review on Natural Bioactive Products as Radioprotective Therapeutics: Present and Past Perspective26
Pharmacological Action and Research Progress of Taraxasterol26
Foldable/Expandable Gastro-retentive Films Based on Starch and Chitosan as a Carrier For Prolonged Release of Resveratrol24
FDA-approved CAR T-cell Therapy: A Decade of Progress and Challenges24
Development and Characterization of an Anti-PD-L1 Immunotoxin for Targeted Cancer Therapy23
Development of Daruharidra (Berberis aristata) Based Biogenic Cadmium Sulfide Nanoparticles: Their Implementation as Antibacterial and Novel Therapeutic Agents against Human Breast and Ovarian Cancer23
0.091808795928955